{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T19:09:24Z","timestamp":1795115364813,"version":"4.10.3"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T00:00:00Z","timestamp":1684886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T00:00:00Z","timestamp":1684886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The aim of this study was to search for key genes in ankylosing spondylitis (AS) through comprehensive bioinformatics analysis, thus providing some theoretical support for future diagnosis and treatment of AS and further research.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Gene expression profiles were collected from Gene Expression Omnibus (GEO,\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ncbi.nlm.nih.gov\/geo\/\">http:\/\/www.ncbi.nlm.nih.gov\/geo\/<\/jats:ext-link>\n                      ) by searching for the term \"ankylosing spondylitis\". Ultimately, two microarray datasets (GSE73754 and GSE11886) were downloaded from the GEO database. A bioinformatic approach was used to screen differentially expressed genes and perform functional enrichment analysis to obtain biological functions and signalling pathways associated with the disease. Weighted correlation network analysis (WGCNA) was used to further obtain key genes. Immune infiltration analysis was performed using the CIBERSORT algorithm to conduct a correlation analysis of key genes with immune cells. The GWAS data of AS were analysed to identify the pathogenic regions of key genes in AS. Finally, potential therapeutic agents for AS were predicted using these key genes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 7 potential biomarkers were identified: DYSF, BASP1, PYGL, SPI1, C5AR1, ANPEP and SORL1. ROC curves showed good prediction for each gene. T cell, CD4 na\u00efve cell, and neutrophil levels were significantly higher in the disease group than in the paired normal group, and key gene expression was strongly correlated with immune cells. CMap results showed that the expression profiles of ibuprofen, forskolin, bongkrek-acid, and cimaterol showed the most significant negative correlation with the expression profiles of disease perturbations, suggesting that these drugs may play a role in AS treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The potential biomarkers of AS screened in this study are closely related to the level of immune cell infiltration and play an important role in the immune microenvironment. This may provide help in the clinical diagnosis and treatment of AS and provide new ideas for further research.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12891-023-06550-3","type":"journal-article","created":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T02:02:09Z","timestamp":1684893729000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Identification of potential biomarkers for ankylosing spondylitis based on bioinformatics analysis"],"prefix":"10.1186","volume":"24","author":[{"given":"Dongxu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruichao","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghuang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenming","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,24]]},"reference":[{"issue":"26","key":"6550_CR1","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1056\/NEJMra1406182","volume":"374","author":"JD Taurog","year":"2016","unstructured":"Taurog JD, Chhabra A, Colbert RA. Ankylosing Spondylitis and Axial Spondyloarthritis. N Engl J Med. 2016;374(26):2563\u201374.","journal-title":"N Engl J Med"},{"issue":"2","key":"6550_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2018-000762","volume":"4","author":"U Lindstr\u00f6m","year":"2018","unstructured":"Lindstr\u00f6m U, et al. Impact of extra-articular spondyloarthritis manifestations and comorbidities on drug retention of a first TNF-inhibitor in ankylosing spondylitis: a population-based nationwide study. RMD Open. 2018;4(2): e000762.","journal-title":"RMD Open"},{"issue":"4","key":"6550_CR3","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1093\/rheumatology\/ket387","volume":"53","author":"LE Dean","year":"2014","unstructured":"Dean LE, et al. Global prevalence of ankylosing spondylitis. Rheumatology (Oxford). 2014;53(4):650\u20137.","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"6550_CR4","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1136\/ard.59.11.883","volume":"59","author":"MA Brown","year":"2000","unstructured":"Brown MA, et al. Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis. Ann Rheum Dis. 2000;59(11):883\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"6550_CR5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrrheum.2015.133","volume":"12","author":"MA Brown","year":"2016","unstructured":"Brown MA, Kenna T, Wordsworth BP. Genetics of ankylosing spondylitis\u2013insights into pathogenesis. Nat Rev Rheumatol. 2016;12(2):81\u201391.","journal-title":"Nat Rev Rheumatol"},{"issue":"8","key":"6550_CR6","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/RHU.0000000000000180","volume":"20","author":"D van der Heijde","year":"2014","unstructured":"van der Heijde D, et al. Referral patterns, diagnosis, and disease management of patients with axial spondyloarthritis. J Clin Rheumatol. 2014;20(8):411\u20137.","journal-title":"J Clin Rheumatol"},{"issue":"4","key":"6550_CR7","first-page":"E11","volume":"51","author":"SL Zuckerman","year":"2021","unstructured":"Zuckerman SL, Goldberg JL, Riew KD. Multilevel anterior cervical osteotomies with uncinatectomies to correct a fixed kyphotic deformity associated with ankylosing spondylitis: technical note and operative video. Neurosurg Focus. 2021;51(4):E11.","journal-title":"Neurosurg Focus"},{"key":"6550_CR8","doi-asserted-by":"crossref","unstructured":"Ritchlin C, Adamopoulos IE. Axial spondyloarthritis: new advances in diagnosis and management. BMJ (Clin Res ed).  2021;372:m4447.","DOI":"10.1136\/bmj.m4447"},{"key":"6550_CR9","doi-asserted-by":"publisher","first-page":"e543","DOI":"10.1016\/j.wneu.2021.11.014","volume":"158","author":"B Wu","year":"2022","unstructured":"Wu B, et al. Potential pathogenic genes and mechanism of ankylosing spondylitis: a study based on WGCNA and bioinformatics analysis. World Neurosurg. 2022;158:e543\u201356.","journal-title":"World Neurosurg"},{"key":"6550_CR10","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.","journal-title":"BMC Bioinformatics"},{"issue":"11","key":"6550_CR11","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1038\/s41588-018-0248-z","volume":"50","author":"O Canela-Xandri","year":"2018","unstructured":"Canela-Xandri O, Rawlik K, Tenesa A. An atlas of genetic associations in UK Biobank. Nat Genet. 2018;50(11):1593\u20139.","journal-title":"Nat Genet"},{"issue":"5","key":"6550_CR12","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453\u20137.","journal-title":"Nat Methods"},{"issue":"D1","key":"6550_CR13","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa M, et al. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 2023;51(D1):D587\u201392.","journal-title":"Nucleic Acids Res"},{"key":"6550_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.854848","volume":"13","author":"P Huang","year":"2022","unstructured":"Huang P, et al. Identification of biomarkers associated With CD4+ T-cell infiltration with gene coexpression network in dermatomyositis. Front Immunol. 2022;13: 854848.","journal-title":"Front Immunol"},{"key":"6550_CR15","doi-asserted-by":"crossref","unstructured":"Subramanian A, et al. A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles. Cell. 2017;171(6):1437-1452.","DOI":"10.1016\/j.cell.2017.10.049"},{"issue":"1","key":"6550_CR16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13075-019-1827-9","volume":"21","author":"K Ermoza","year":"2019","unstructured":"Ermoza K, et al. Tolerogenic XCR1(+) dendritic cell population is dysregulated in HLA-B27 transgenic rat model of spondyloarthritis. Arthritis Res Ther. 2019;21(1):46.","journal-title":"Arthritis Res Ther"},{"key":"6550_CR17","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1146\/annurev-immunol-032414-112110","volume":"33","author":"P Bowness","year":"2015","unstructured":"Bowness P. HLA-B27. Annu Rev Immunol. 2015;33:29\u201348.","journal-title":"Annu Rev Immunol"},{"issue":"7568","key":"6550_CR18","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1136\/bmj.38954.689583.DE","volume":"333","author":"CM McVeigh","year":"2006","unstructured":"McVeigh CM, Cairns AP. Diagnosis and management of ankylosing spondylitis. BMJ (Clin Res ed). 2006;333(7568):581\u20135.","journal-title":"BMJ (Clin Res ed)"},{"issue":"4","key":"6550_CR19","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s40265-019-01075-3","volume":"79","author":"HA Blair","year":"2019","unstructured":"Blair HA. Secukinumab: A Review in Ankylosing Spondylitis. Drugs. 2019;79(4):433\u201343.","journal-title":"Drugs"},{"key":"6550_CR20","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41413-019-0057-8","volume":"7","author":"W Zhu","year":"2019","unstructured":"Zhu W, et al. Ankylosing spondylitis: etiology, pathogenesis, and treatments. Bone Res. 2019;7:22.","journal-title":"Bone Res"},{"issue":"4","key":"6550_CR21","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.4049\/jimmunol.1002653","volume":"186","author":"P Bowness","year":"2011","unstructured":"Bowness P, et al. Th17 cells expressing KIR3DL2+ and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis. J Immunol (Baltimore, Md 1950). 2011;186(4):2672\u201380.","journal-title":"J Immunol (Baltimore, Md. 1950)"},{"key":"6550_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.956027","volume":"13","author":"Y Han","year":"2022","unstructured":"Han Y, et al. Identification of diagnostic mRNA biomarkers in whole blood for ankylosing spondylitis using WGCNA and machine learning feature selection. Front Immunol. 2022;13: 956027.","journal-title":"Front Immunol"},{"issue":"1","key":"6550_CR23","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13075-020-02226-8","volume":"22","author":"M Yang","year":"2020","unstructured":"Yang M, et al. TNF-alpha inhibitor therapy can improve the immune imbalance of CD4+ T cells and negative regulatory cells but not CD8+ T cells in ankylosing spondylitis. Arthritis Res Ther. 2020;22(1):149.","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"6550_CR24","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1136\/annrheumdis-2014-206119","volume":"75","author":"J Fessler","year":"2016","unstructured":"Fessler J, et al. Premature senescence of T-cell subsets in axial spondyloarthritis. Ann Rheum Dis. 2016;75(4):748\u201354.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"6550_CR25","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1159\/000484250","volume":"85","author":"S Dulic","year":"2018","unstructured":"Dulic S, et al. The impact of Anti-TNF therapy on CD4+ and CD8+ cell subsets in ankylosing spondylitis. Pathobiology. 2018;85(3):201\u201310.","journal-title":"Pathobiology"},{"issue":"2","key":"6550_CR26","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41423-021-00832-3","volume":"19","author":"A Herrero-Cervera","year":"2022","unstructured":"Herrero-Cervera A, Soehnlein O, Kenne E. Neutrophils in chronic inflammatory diseases. Cell Mol Immunol. 2022;19(2):177\u201391.","journal-title":"Cell Mol Immunol"},{"issue":"10","key":"6550_CR27","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/apm.12722","volume":"125","author":"Z Yang","year":"2017","unstructured":"Yang Z, et al. Comparisons of neutrophil-, monocyte-, eosinophil-, and basophil- lymphocyte ratios among various systemic autoimmune rheumatic diseases. APMIS. 2017;125(10):863\u201371.","journal-title":"APMIS"},{"key":"6550_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.949882","volume":"13","author":"C Zhou","year":"2022","unstructured":"Zhou C, et al. Immune cell infiltration-related clinical diagnostic model for Ankylosing Spondylitis. Front Genet. 2022;13: 949882.","journal-title":"Front Genet"},{"key":"6550_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.dci.2020.103666","volume":"108","author":"FJ Martinez-Navarro","year":"2020","unstructured":"Martinez-Navarro FJ, et al. The vitamin B6-regulated enzymes PYGL and G6PD fuel NADPH oxidases to promote skin inflammation. Dev Comp Immunol. 2020;108: 103666.","journal-title":"Dev Comp Immunol"},{"issue":"3","key":"6550_CR30","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/eji.202149481","volume":"52","author":"R Borella","year":"2022","unstructured":"Borella R, et al. Metabolic reprograming shapes neutrophil functions in severe COVID-19. Eur J Immunol. 2022;52(3):484\u2013502.","journal-title":"Eur J Immunol"},{"key":"6550_CR31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.smim.2018.03.002","volume":"37","author":"CD Sadik","year":"2018","unstructured":"Sadik CD, et al. The critical role of C5a as an initiator of neutrophil-mediated autoimmune inflammation of the joint and skin. Semin Immunol. 2018;37:21\u20139.","journal-title":"Semin Immunol"},{"key":"6550_CR32","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.3389\/fimmu.2019.01866","volume":"10","author":"QY Zheng","year":"2019","unstructured":"Zheng QY, et al. C5a\/C5aR1 pathway is critical for the pathogenesis of psoriasis. Front Immunol. 2019;10:1866.","journal-title":"Front Immunol"},{"issue":"2","key":"6550_CR33","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00401-019-01991-4","volume":"138","author":"D Campion","year":"2019","unstructured":"Campion D, Charbonnier C, Nicolas G. SORL1 genetic variants and Alzheimer disease risk: a literature review and meta-analysis of sequencing data. Acta Neuropathol. 2019;138(2):173\u201386.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"6550_CR34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s40478-021-01140-7","volume":"9","author":"G Monti","year":"2021","unstructured":"Monti G, et al. Expression of an alternatively spliced variant of SORL1 in neuronal dendrites is decreased in patients with Alzheimer\u2019s disease. Acta Neuropathol Commun. 2021;9(1):43.","journal-title":"Acta Neuropathol Commun"},{"key":"6550_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.861459","volume":"13","author":"J Jiang","year":"2022","unstructured":"Jiang J, et al. Upregulated of ANXA3, SORL1, and Neutrophils May Be Key Factors in the Progressionof Ankylosing Spondylitis. Front Immunol. 2022;13: 861459.","journal-title":"Front Immunol"},{"issue":"1","key":"6550_CR36","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/1682","volume":"20","author":"J Liu","year":"1998","unstructured":"Liu J, et al. Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat Genet. 1998;20(1):31\u20136.","journal-title":"Nat Genet"},{"key":"6550_CR37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.trsl.2022.04.001","volume":"247","author":"X Zhang","year":"2022","unstructured":"Zhang X, et al. DYSF promotes monocyte activation in atherosclerotic cardiovascular disease as a DNA methylation-driven gene. Transl Res. 2022;247:19\u201338.","journal-title":"Transl Res"},{"key":"6550_CR38","doi-asserted-by":"publisher","first-page":"637829","DOI":"10.3389\/fimmu.2021.637829","volume":"12","author":"C Schinocca","year":"2021","unstructured":"Schinocca C, et al. Role of the IL-23\/IL-17 pathway in rheumatic diseases: an overview. Front Immunol. 2021;12:637829.","journal-title":"Front Immunol"},{"issue":"2","key":"6550_CR39","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.cyto.2015.01.003","volume":"75","author":"C Konya","year":"2015","unstructured":"Konya C, et al. Update on the role of Interleukin 17 in rheumatologic autoimmune diseases. Cytokine. 2015;75(2):207\u201315.","journal-title":"Cytokine"},{"issue":"1","key":"6550_CR40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12865-022-00476-6","volume":"23","author":"T Liang","year":"2022","unstructured":"Liang T, et al. STAT3 and SPI1, may lead to the immune system dysregulation and heterotopic ossification in ankylosing spondylitis. BMC Immunol. 2022;23(1):3.","journal-title":"BMC Immunol"},{"key":"6550_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcp.2019.101504","volume":"50","author":"C-P Xia","year":"2020","unstructured":"Xia C-P, et al. Sp1 promotes dental pulp stem cell osteoblastic differentiation through regulating noggin. Mol Cell Probes. 2020;50: 101504.","journal-title":"Mol Cell Probes"},{"issue":"3","key":"6550_CR42","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41577-020-00426-6","volume":"21","author":"H Hosokawa","year":"2021","unstructured":"Hosokawa H, Rothenberg EV. How transcription factors drive choice of the T cell fate. Nat Rev Immunol. 2021;21(3):162\u201376.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"6550_CR43","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1038\/s41467-021-22548-8","volume":"12","author":"S Watt","year":"2021","unstructured":"Watt S, et al. Genetic perturbation of PU.1 binding and chromatin looping at neutrophil enhancers associates with autoimmune disease. Nat Commun. 2021;12(1):2298.","journal-title":"Nat Commun"},{"key":"6550_CR44","doi-asserted-by":"crossref","unstructured":"Tu, J., et al., PU.1 promotes development of rheumatoid arthritis via repressing FLT3 in macrophages and fibroblast-like synoviocytes. Ann Rheum Dis, 2022.","DOI":"10.1136\/ard-2022-222708"},{"key":"6550_CR45","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jneuroim.2018.06.010","volume":"323","author":"L Shakerian","year":"2018","unstructured":"Shakerian L, et al. MicroRNA-150 targets PU.1 and regulates macrophage differentiation and function in experimental autoimmune encephalomyelitis. J Neuroimmunol. 2018;323:167\u201374.","journal-title":"J Neuroimmunol"},{"issue":"10","key":"6550_CR46","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1002\/jnr.21678","volume":"86","author":"I Korshunova","year":"2008","unstructured":"Korshunova I, et al. Characterization of BASP1-mediated neurite outgrowth. J Neurosci Res. 2008;86(10):2201\u201313.","journal-title":"J Neurosci Res"},{"issue":"1","key":"6550_CR47","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/82881","volume":"4","author":"HM Bomze","year":"2001","unstructured":"Bomze HM, et al. Spinal axon regeneration evoked by replacing two growth cone proteins in adult neurons. Nat Neurosci. 2001;4(1):38\u201343.","journal-title":"Nat Neurosci"},{"issue":"14","key":"6550_CR48","doi-asserted-by":"publisher","first-page":"5604","DOI":"10.1073\/pnas.0812101106","volume":"106","author":"M Hartl","year":"2009","unstructured":"Hartl M, et al. Inhibition of Myc-induced cell transformation by brain acid-soluble protein 1 (BASP1). Proc Natl Acad Sci USA. 2009;106(14):5604\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"6550_CR49","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1681\/ASN.2009020227","volume":"21","author":"MD Sanchez-Ni\u00f1o","year":"2010","unstructured":"Sanchez-Ni\u00f1o MD, et al. BASP1 promotes apoptosis in diabetic nephropathy. J Am Soc Nephrol. 2010;21(4):610\u201321.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"6550_CR50","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4049\/jimmunol.1900868","volume":"204","author":"C Lu","year":"2020","unstructured":"Lu C, Amin MA, Fox DA. CD13\/Aminopeptidase N is a potential therapeutic target for inflammatory disorders. J Immunol. 2020;204(1):3\u201311.","journal-title":"J Immunol"},{"issue":"5","key":"6550_CR51","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/ng.3528","volume":"48","author":"D Ellinghaus","year":"2016","unstructured":"Ellinghaus D, et al. Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci. Nat Genet. 2016;48(5):510\u20138.","journal-title":"Nat Genet"},{"issue":"9","key":"6550_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1005535","volume":"11","author":"M van de Bunt","year":"2015","unstructured":"van de Bunt M, et al. Evaluating the performance of fine-mapping strategies at common variant GWAS Loci. PLoS Genet. 2015;11(9): e1005535.","journal-title":"PLoS Genet"},{"key":"6550_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.603726","volume":"12","author":"BP Wordsworth","year":"2021","unstructured":"Wordsworth BP, et al. Perspectives on the Genetic Associations of Ankylosing Spondylitis. Front Immunol. 2021;12: 603726.","journal-title":"Front Immunol"},{"issue":"8","key":"6550_CR54","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/ng.873","volume":"43","author":"DM Evans","year":"2011","unstructured":"Evans DM, et al. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet. 2011;43(8):761\u20137.","journal-title":"Nat Genet"},{"key":"6550_CR55","doi-asserted-by":"publisher","first-page":"624632","DOI":"10.3389\/fimmu.2021.624632","volume":"12","author":"Z Nancy","year":"2021","unstructured":"Nancy Z, et al. From the genetics of ankylosing spondylitis to new biology and drug target discovery. Front Immunol. 2021;12:624632.","journal-title":"Front Immunol"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-023-06550-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-023-06550-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-023-06550-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T03:03:55Z","timestamp":1684897435000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-023-06550-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,24]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["6550"],"URL":"https:\/\/doi.org\/10.1186\/s12891-023-06550-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2514310\/v1","asserted-by":"object"}]},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,24]]},"assertion":[{"value":"25 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"413"}}